Pharma pledges help on patient access to chronic-disease meds

Drugmakers are pledging to help revamp drug distribution and grapple with other obstacles to patient access to medicines in developing countries, the Financial Times reports. Prices aren't the issue, companies say, but rather infrastructure. Report

Suggested Articles

Download our solutions overview to discover how CoverMyMeds can make a difference for your brand.

In a bladder cancer field chock-full of checkpoint inhibitors, Pfizer and Merck KGaA’s Bavencio has a chance to get ahead thanks to new data.

The FDA backtracked on its earlier testing and found NDMA contamination in the extended release formulation of certain generic versions of metformin.